Bei-Qing Pan

1.3k total citations
14 papers, 924 citations indexed

About

Bei-Qing Pan is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Bei-Qing Pan has authored 14 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Surgery. Recurrent topics in Bei-Qing Pan's work include Bone Metabolism and Diseases (4 papers), Bone health and treatments (3 papers) and RNA modifications and cancer (3 papers). Bei-Qing Pan is often cited by papers focused on Bone Metabolism and Diseases (4 papers), Bone health and treatments (3 papers) and RNA modifications and cancer (3 papers). Bei-Qing Pan collaborates with scholars based in China, Australia and United States. Bei-Qing Pan's co-authors include Andrew C.W. Zannettino, David M. Findlay, Amanda Farrugia, Gerald J. Atkins, Luen Bik To, P. Kostakis, Changchun Deng, Owen A. O’Connor, Stan Gronthos and Andreas Evdokiou and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Clinical Cancer Research.

In The Last Decade

Bei-Qing Pan

14 papers receiving 912 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bei-Qing Pan China	12	566	482	202	142	99	14	924
Amanda Farrugia Australia	9	659 1.2×	502 1.0×	215 1.1×	306 2.2×	65 0.7×	11	1.0k
K. Yamaguchi Japan	10	591 1.0×	835 1.7×	259 1.3×	54 0.4×	43 0.4×	22	1.2k
Manali Bendre United States	7	578 1.0×	551 1.1×	88 0.4×	89 0.6×	21 0.2×	8	990
Emerence Crompot Belgium	13	306 0.5×	301 0.6×	170 0.8×	47 0.3×	42 0.4×	19	734
Ya‐Wei Qiang United States	16	685 1.2×	1.1k 2.2×	78 0.4×	620 4.4×	95 1.0×	35	1.6k
Caroline Wilson United Kingdom	14	464 0.8×	137 0.3×	92 0.5×	61 0.4×	58 0.6×	40	799
Ryotaro Iwasaki Japan	14	381 0.7×	587 1.2×	159 0.8×	78 0.5×	74 0.7×	21	1.0k
Marina Bolzoni Italy	19	610 1.1×	562 1.2×	63 0.3×	635 4.5×	58 0.6×	51	1.2k
Rasesh Kapadia United States	13	428 0.8×	612 1.3×	237 1.2×	34 0.2×	35 0.4×	15	1.0k
Benedetta Dalla Palma Italy	15	379 0.7×	326 0.7×	45 0.2×	384 2.7×	37 0.4×	41	733

Countries citing papers authored by Bei-Qing Pan

Since Specialization

Citations

This map shows the geographic impact of Bei-Qing Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bei-Qing Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bei-Qing Pan more than expected).

Fields of papers citing papers by Bei-Qing Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bei-Qing Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bei-Qing Pan. The network helps show where Bei-Qing Pan may publish in the future.

Co-authorship network of co-authors of Bei-Qing Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Bei-Qing Pan. A scholar is included among the top collaborators of Bei-Qing Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bei-Qing Pan. Bei-Qing Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

He, Yayi, Shengxiang Ren, Jun Zhu, et al.. (2021). Phase Ia/Ib dose-escalation study of IBI110 (anti-LAG-3 mAb) as a single agent and in combination with sintilimab (anti-PD-1 mAb) in patients (pts) with advanced solid tumors.. Journal of Clinical Oncology. 39(15_suppl). 2589–2589. 1 indexed citations

Pan, Bei-Qing, Zhihui Xie, Jia‐Jie Hao, et al.. (2019). PTP1B up-regulates EGFR expression by dephosphorylating MYH9 at Y1408 to promote cell migration and invasion in esophageal squamous cell carcinoma. Biochemical and Biophysical Research Communications. 522(1). 53–60. 14 indexed citations

Liu, Tingting, Jing Yu, Yingya Cao, et al.. (2018). Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma. Journal of Molecular Medicine. 96(8). 807–817. 13 indexed citations

Shi, Chao, Bei-Qing Pan, Feng Shi, et al.. (2018). Sequestosome 1 protects esophageal squamous carcinoma cells from apoptosis via stabilizing SKP2 under serum starvation condition. Oncogene. 37(24). 3260–3274. 20 indexed citations

Wang, Chunli, et al.. (2015). [IGHMBP2 overexpression promotes cell migration and invasion in esophageal squamous carcinoma].. PubMed. 37(4). 360–366. 4 indexed citations

Shi, Feng, Shang Li, Bei-Qing Pan, et al.. (2014). Calreticulin Promotes Migration and Invasion of Esophageal Cancer Cells by Upregulating Neuropilin-1 Expression via STAT5A. Clinical Cancer Research. 20(23). 6153–6162. 45 indexed citations

Pan, Bei-Qing & Suzanne Lentzsch. (2012). The application and biology of immunomodulatory drugs (IMiDs) in cancer. Pharmacology & Therapeutics. 136(1). 56–68. 59 indexed citations

Pan, Bei-Qing, et al.. (2012). Secondary tumors of the pancreas: a case series.. PubMed. 32(4). 1449–52. 20 indexed citations

Deng, Changchun, Bei-Qing Pan, & Owen A. O’Connor. (2012). Brentuximab Vedotin. Clinical Cancer Research. 19(1). 22–27. 120 indexed citations

10.

Findlay, David M., et al.. (2006). Evidence for reduced bone formation surface relative to bone resorption surface in female femoral fragility fracture patients. Bone. 39(6). 1226–1235. 17 indexed citations

11.

Pan, Bei-Qing, Amanda Farrugia, Luen Bik To, et al.. (2004). The Nitrogen-Containing Bisphosphonate, Zoledronic Acid, Influences RANKL Expression in Human Osteoblast-Like Cells by Activating TNF-α Converting Enzyme (TACE). Journal of Bone and Mineral Research. 19(1). 147–154. 137 indexed citations

12.

Farrugia, Amanda, Gerald J. Atkins, Luen Bik To, et al.. (2003). Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo.. PubMed. 63(17). 5438–45. 177 indexed citations

13.

Pan, Bei-Qing, Luen Bik To, Amanda Farrugia, et al.. (2003). The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone. 34(1). 112–123. 96 indexed citations

14.

Atkins, Gerald J., P. Kostakis, Bei-Qing Pan, et al.. (2003). RANKL Expression Is Related to the Differentiation State of Human Osteoblasts. Journal of Bone and Mineral Research. 18(6). 1088–1098. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact